CXCL5 and neoplasm: Upregulation of CXCL5 expression in tumor was found to be a favorable prognostic factor for both OS and DFS, and none of the analyzed clinicopathologic characteristics (patients’ age, gender, stage, or tumor histological type) influenced these associations.